Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Fibrous Dysplasia

Albright Syndrome

Eligibility:

All Genders

10+ years

Brief Summary

PTH secretion defects (grouped under the name hypoparathyroidism) are due to abnormalities in the PTH gene, abnormalities in the development of the parathyroid glands which synthesize PTH or abnormali...

Eligibility Criteria

Inclusion

  • Pediatric patients :
  • Children from 10 to 18 years old
  • Patients with Fibrous dysplasia / McCune-Albright syndrome,hypoparathyroïdism, hyperparathyroïdism, or iPPSD, from References Centers for rare diseases (Calcium and phosphate metabolism, constitutional bone diseases) followed at hôpital Femme Mère Enfant (Bron) or at hôpital Bicêtre Paris Saclay (Paris).
  • Patients and parent / holder of parental authority who have been informed of the study and do not object to participate
  • • Adults:
  • Patients \> 18 years old
  • Patients with Fibrous dysplasia / McCune-Albright syndrome, followed in reference center for constitutional bone diseases at hôpital Edouard Herriot (Lyon)
  • Patients who have been informed of the study and do not object to participate

Exclusion

  • Children \< 8 kg
  • Patient with hepatic disease
  • Patients under tutorship or curatorship
  • Pregnant and / or breastfeeding woman
  • Patient deprived of liberty
  • Patient in emergency situation who can not agree to participate

Key Trial Info

Start Date :

March 10 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 11 2023

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT04671719

Start Date

March 10 2021

End Date

January 11 2023

Last Update

March 24 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Centre de compétence des maladies rares de l'insulino-sécrétion et de l'insulino-sensibilité

Bron, France, 69500

2

Centre de référence Dysplasie Fibreuse des os Service rhumatologie et pathologie osseuse Hôpital Edouard Herriot, Lyon

Lyon, France, 69003

3

Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate Service d'Endocrinologie et Diabète de l'Enfant Hôpital Bicêtre Paris Saclay

Paris, France, 94270